Research and Markets (http://www.researchandmarkets.com/research/hd82qr/diagnostics)
has announced the addition of the "Diagnostics
Partnering Yearbook 2013" report to their offering.
The Diagnostics Partnering Yearbook 2013 report series provides
comprehensive understanding and unprecedented access to the partnering
deals and agreements entered into by the worlds leading healthcare
companies during 2012.
Using these reports, dealmakers will effectively and efficiently gain
insight into the partnering activities of the past year. The report
series allows you to view all the partnering and alliances deals
The initial chapters of this report provide an orientation of 2012's
dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2012
covering trends by deal type, stage of development, technology type and
Chapter 2 provides a review of the leading deals during 2012. Deals are
listed by headline value, signed by bigpharma and bigbiotech, and most
active bigpharma. Where the deal has an agreement contract published at
the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive directory of all partnering deals
announced during 2012.
The chapter is organized by company A-Z, stage of development at
signing, deal type (collaborative R&D, co-promotion, licensing etc),
therapy area and technology type. Each deal title links via Weblink to
an online version of the deal record and where available, the contract
document, providing easy access to each contract document on demand.
The report series also includes numerous tables and figures that
illustrate the trends and activities in bigpharma partnering and
dealmaking during 2012.
In conclusion, this report provides everything a prospective dealmaker
needs to know about partnering in the research, development and
commercialization of technologies and products during 2012.
For more information visit http://www.researchandmarkets.com/research/hd82qr/diagnostics
[ Back To NFVZone's Homepage ]